drugset / Trial / NCT01588457

Sequential Multiple Assignment Treatment for Bipolar Disorder

NCT01588457

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare which of the two mood stabilizers (drugs that help to steady/stabilize mood in patients with bipolar disorder (BD)), lithium and divalproex, is more effective in patients with bipolar disorder over 26 weeks. The study will also compare if lithium or divalproex used alone versus lithium or divalproex used with quetiapine versus lithium or divalproex used with lamotrigine is more effective when symptoms of depression develop.

Timeline

Start
2011-06
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Divalproex Sodium Small molecule
Comparator Lamotrigine Small molecule 200 mg
Comparator Lamotrigine Small molecule 400 mg
Comparator Lithium Unknown
Comparator Quetiapine Small molecule 300 mg